Cancer Gene Therapy - Table of Contents alert Volume 22 Issue 12

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 22, Issue 12 (December 2015) In this issue Editorial Review Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement SUBMIT TO CANCER GENE THERAPY - Over 105,000 eAlert registrants will receive your paper in their inbox - Average of 83,000 page views across the Cancer Gene Therapy website - On average, authors receive a first decision on their paper within 34 working days - Impact Factor of 2.416, 64/123 in Medicine, Research & Experimental category    (2014 Journal Citation Reports®, Thomson Reuters) Find out how to submit your research today   Editorial Top Navigating the regulatory road to approval for cancer gene therapies S K Libutti Cancer Gene Ther 2015 22: 553; 10.1038/cgt.2015.62 Full Text Review Top Gene therapy for cancer: regulatory considerations for approval OPEN S R Husain, J Han, P Au, K Shannon and R K Puri Cancer Gene Ther 2015 22: 554-563; advance online publication, November 20, 2015; 10.1038/cgt.2015.58 Abstract | Full Text Original Articles Top Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2 W Ruoming, Y Zhen, Z Tengteng and H Jisheng Cancer Gene Ther 2015 22: 564-572; advance online publication, October 23, 2015; 10.1038/cgt.2015.41 Abstract | Full Text Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia X Zhu, H Zhao, Z Lin and G Zhang Cancer Gene Ther 2015 22: 573-580; advance online publication, October 23, 2015; 10.1038/cgt.2015.50 Abstract | Full Text HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer R Muralidharan, J Panneerselvam, A Chen, Y D Zhao, A Munshi and R Ramesh Cancer Gene Ther 2015 22: 581-590; advance online publication, October 23, 2015; 10.1038/cgt.2015.55 Abstract | Full Text Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma Amudhan Pugalenthi, Kelly Mojica, Justin W Ady, Clark Johnsen, Damon Love, Nanhai G Chen, Richard J Aguilar, Aladar A Szalay and Yuman Fong Cancer Gene Ther 2015 22: 591-596; advance online publication, November 20, 2015; 10.1038/cgt.2015.60 Abstract | Full Text Advertisement Social Media Guide for Authors  Nearly 50% of researchers engage in scientific discussion on Twitter* Learn how to make your research part of the conversation. *Source: Nature, Online collaboration: Scientists and the social network (doi:10.1038/512126a) Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.